The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
Novel device shows potential in better detecting oral cancer

Researchers supported by the National Institute of Dental and Craniofacial Research, part of the National Institutes of Health, report today their initial success using a customized optical device that allows dentists to visualize in a completely new way whether a patient might have a developing oral cancer.

Called a Visually Enhanced Lesion Scope (VELScope), this simple, hand-held device emits a cone of blue light into the mouth that excites various molecules within our cells, causing them to absorb the light energy and re-emit it as visible fluorescence. Remove the light, and the fluorescence of the tissue is no longer visible.

Because changes in the natural fluorescence of healthy tissue generally reflect light-scattering biochemical or structural changes indicative of developing tumor cells, the VELScope allows dentists to shine a light onto a suspicious sore in the mouth, look through an attached eyepiece, and watch directly for changes in color. Normal oral tissue emits a pale green fluorescence, while potentially early tumor, or dysplastic, cells appear dark green to black.

Testing the device in 44 people, the results of which are published online in the Journal of Biomedical Optics, the scientists found they could distinguish correctly in all but one instance between normal and abnormal tissue. Their diagnoses were confirmed to be correct by biopsy and standard pathology.

"The natural fluorescence of the mouth is invisible to the naked eye," said Dr. Miriam Rosin, a senior author on the paper and a cancer biologist at the British Columbia Cancer Research Center in Vancouver, Canada. "The VELScope literally brings this natural fluorescence to light, helping dentists to answer in a more informed way a common question in daily practices: To biopsy or not to biopsy."

Because developing tumors in the mouth are often easily visible, public health officials have long advocated early detection of oral cancer. But dete
'"/>

Contact: Bob Kuska
kuskar@nidcr.nih.gov
301-594-7560
NIH/National Institute of Dental and Craniofacial Research
10-Apr-2006


Page: 1 2 3

Related medicine news :

1. Novel candidate biomarker for heart failure also strongly predicts risk of death
2. Novel treatments may help alleviate constipation, IBS in women
3. Novel catheter technique successfully patches holes in the heart
4. Novel anti-oxidant and anti-inflammatory agent shows effectiveness on key endpoints in trial
5. Novel Ames Lab composite may replace depleted uranium
6. Novel computed imaging technique uses blurry images to enhance view
7. Novel brain areas associated with the recognition of gender, ethnicity and the identity of faces
8. Novel program enhances dementia caregivers quality of life
9. Novel gene therapy may lead to cure in hemophilia A patients
10. Novel therapy combinations gain ground in treating hepatitis
11. Novel stem cell technology leads to better spinal cord repair

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Novel device shows potential better detecting oral cancer

(Date:11/23/2009)...action might ease the problem, researchers say , ... who bottle up their anger over unfair treatment a...h study indicates. , Men who consistently faile...a fellow worker or supervisor were more than twice...disease as those who vented their anger, claims a ...
(Date:11/23/2009).../PRNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFL...solutionsforthehealthcareandcommercialindustries,a...edServicesatSiemensHealthServices,hasjoinedInfoLog..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...icHealthcareServicesforInfoLogix,Mr.Waywillberespo...
(Date:11/23/2009)...PRNewswire-USNewswire/--TheAmericanSocietyofHemato...ng,education,andmediacompany,arelaunching"Exploret...dtosparkinterestinthefieldsofscienceandmedicine,in...itiesinhematology. ,, "Manyhematologistsmayreme...ficent,whichmadelearningaboutbloodreallyfun,"state...
(Date:11/23/2009)... patients and survivors treated with chemotherapy ...me chronic conditions, hindering patients, ability...University of Rochester Medical Center. , A stud...leep troubles at nearly three times the rate of th...nt in younger patients and those with lung and bre...
(Date:11/23/2009)...are professionals enjoy a pay raise for a job well... for health care performance may actually backfire...performance ratings for 25 medical groups across C...nch of a statewide pay-for-performance program in ...productivity. , Reporting in the December edi...
Breaking Medicine News(10 mins):Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
(Date:11/23/2009)...,, EXTON,Pa.,Nov.23/PRNewswire/--BioTrendsRe...(TM): Feraheme report,thesecondinamulti-phasesyn...G,snewIVironproduct,Feraheme,throughthefirstsixmon...esquantitativeinformationfrom50uniqueNephrologists...sassesstrialanduseofFeraheme,obstaclestouse,reason...
(Date:11/23/2009)...,, WALTHAM,Mass.,Nov.23/PRNewswire/--Proteon...alstudyofitsleadproduct,PRT-201,inend-stagerenaldi...usgraft(AVG)creation.TheAVGstudyrepresentsProteon,...eviouslyannouncingtheinitiationofaPhase1/2studyofP...ousfistula(AVF)creationearlierthisyear.Proteonalso...
(Date:11/23/2009)...,, SOUTHSANFRANCISCO,Calif.,Nov.23/PRNewswir...uncedthatDr.TedW.LoveandDr.DavidC.U,Prichardhaveag...etionoftheproposedmergerbetweenAnesivaandArcionThe...ldervotescheduledtotakeplaceatthepreviouslyannounc...nDecember3,2009at9:00a.m.PSTat400OysterPoint,Suite...
Breaking Medicine Technology:Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Study examines dietary influences of liver disease 50559 1Study examines dietary influences of liver disease 50559 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 1Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 2Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement 12874 3TeamHealth Recognized by National Quality Agency 50555 1TeamHealth Recognized by National Quality Agency 50555 2TeamHealth Recognized by National Quality Agency 50555 3
Other News:
...and totaled $1.47 billion in FY2002, according to ...Hopkins Bloomberg School of Public Health. The sum...nsurancepaid for by state and federal funds, priva...the uninsured themselves. The results of the study...
...necology (AJOG), known popularly as "The Gray Jour...pecifically designed to improve the flow of inform...007 issue, it has adopted a multidimensional, mult...nd format to help physicians deal with the challen...
...le can lead to an increased risk of falling during...the latest issue of The Journal of Gerontology: Me...tion devoted to sleep disorders, this edition of t...opic.... A team of Australian researchers found a ...
...ew study shows that young transplant patients in t... likely to stop taking necessary anti-rejection dr...nsplanted organs. The study appears in the latest ...ressive drugs that prevent organ rejection are inc...
health news:Absence of health insurance coverage costs $1.47B in Maryland 2health news:American Journal of Obstetrics & Gynecology relaunched 2health news:American Journal of Obstetrics & Gynecology relaunched 3health news:Teens may lose transplanted organs when insurance runs out 2
...Tenn., August 26, 2002) Blocking a specific signa...re susceptible to the effects of radiation and imp...r scientists have demonstrated.... The study, publ...esearch, shows a potential way to overcome an iron...
DALLAS, Aug. 27 Long-term use of a vasodilator drug can significantly increase survival and improve quality of life in patients with primary pulmonary hypertension (PPH), according to the first multi
... Using transplants of bone marrow cells improved ...ding to a study published in the August 27 issue o...n Academy of Neurology. ...... The rats treated wi...l cells (mature cells from bone marrow) had signif...
...LLE, Va., August 27 The popular herbal supplement...y $70 million in 1998, according to industry figur...fically proven to be effective in clinical researc...olds, University of Virginia Health System investi...
health news:Blocking pathway overcomes tumor vessel resistance to radiation 2health news:Drug improves survival in primary pulmonary hypertension patients 2health news:Drug improves survival in primary pulmonary hypertension patients 3health news:Cell transplants look promising for stroke recovery 2health news:$2.2 Million herbal cold remedy study underway at U.Va. 2